Needle shield and needle concealment device and method for injection system

By introducing a telescopic sleeve structure into the injection system, the problems of accidental needle penis and mechanical damage during the needle penis removal process are solved, safe and controlled needle penis removal and drug preservation are achieved, and medical waste is reduced .

CN119095638APending Publication Date: 2024-12-06CREDENCE MEDSYSTEMS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380033864.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-13
Filing Date
2023-04-13
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing injection systems are at risk of accidental acupuncture and mechanical damage when removing the needle cover, and lack effective control and safety, resulting in medical waste and shortage of medicines.

Method used

A needle cover operating device including a telescopic sleeve is designed, which reduces the force required for the needle shield to remove from the needle seat by means of elastic material and movable members. and protect the needle during removal to prevent accidental stabbing and mechanical damage.

Benefits of technology

The needle cover is safe, controlled and efficient removal is achieved, reducing the risk of accidental acupuncture, improving safety of use, and allowing exhaust and overpressure removal in the injection system to avoid waste of medicine.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095638A_ABST
    Figure CN119095638A_ABST
Patent Text Reader

Abstract

A system for injection includes a syringe body having a proximal end and a distal end and defining a syringe interior. The system also includes a stop member disposed inside the syringe. The system also includes a plunger member coupled to the stop member and configured to be manipulated to insert the stop member distally into the syringe interior relative to the syringe body. Further, the system includes a needle hub assembly coupled to the syringe body at a distal end thereof and including a needle hub and a needle coupled to the needle hub. In addition, the system includes a needle shield removably coupled to the needle hub across the needle. The system also includes a telescopic sleeve coupled to the distal end of the syringe body at least partially over the needle shield.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates generally to injection systems, devices, and processes that facilitate varying degrees of control over the injection process, and more particularly to devices and methods for handling needle shields for injection systems in a healthcare setting, with or without safety features that differ from those of needle shield handling devices. Background Art

[0002] Millions of syringes are consumed every day in healthcare settings, e.g. Figure 1A (2) as shown. A typical syringe (2) includes a tubular body (4), a plunger (6) and an injection needle (8). Figure 1B As shown, such a syringe (2) can be used not only to inject fluid into a patient's body, but also to extract or discharge fluid from a container such as a medicine bottle, a medicine vial, a bag, or other drug containing system (10). In fact, due to regulatory restrictions in some countries such as the United States and considerations of aseptic maintenance, when a medicine bottle (10) with a syringe (2) is used in a patient-specific environment, such a medicine bottle can only be used for a single patient and must then be disposed of - resulting in a large amount of medical waste in the disposal of medicine bottles and remaining medicines, and even causing periodic shortages of certain key drugs. Reference Figure 2A , showing three Luer-type syringes (12), each having a distally disposed Luer fitting geometry (14) so ​​that they can be coupled with other devices having similar mating geometry, e.g. Figure 2B The Luer multi-tip catheter assembly (16) shown. With or without an IV bag, Figure 2B The Luer Multi-Tip Catheter Assemblies can be used to administer liquid medications intravenously to patients. Figure 2A The Luer connector (14) of the syringe may be referred to as a "male" Luer connector, while Figure 2B(18) may be referred to as a "female" Luer connector; one of the Luer interfaces may be threaded (in which case the configuration may be referred to as a "Luer lock" configuration) so that the two sides may be connected by relative rotation, which may be combined with a compressive load. In other words, in one Luer lock embodiment, rotation (possibly accompanied by compression) may be used to engage threads within the male connector (14), which threads are configured to engage flanges on the female connector (18) and bring the device together into a fluid-tight connection. In another embodiment, a tapered interface geometry may be used to provide a Luer engagement by compression without threads or rotation (such a configuration may be referred to as a "slip-on" or "conical" Luer configuration). Although such Luer connections are considered relatively safe for the operator, there is a risk of drug spillage / leakage and part breakage during assembly of the Luer connection. On the other hand, the use of a needle injection configuration carries the risk of a sharp needle contacting or stabbing an unwanted person or structure. For this reason, so-called "safety syringes" have been developed.

[0003] Figure 3 An embodiment of a safety syringe (20) is shown in which a tubular shield member (22) is spring biased to cover the needle (8) when released from a proximal / retracted position relative to the syringe body (4). The tubular needle shield (22) is "locked" in the distal / extended configuration so that the needle shield (22) can no longer return to the proximal / retracted position to prevent accidental needle sticks after injection.

[0004] Figure 4A-4B Another embodiment of a safety syringe (24) is shown. With this configuration, after the plunger (6) is fully inserted relative to the syringe body (4), the retractable needle (26) is configured to retract (28, 26) to a safe position within the tubular body (4), such as Figure 4B Such a configuration, which is configured to collapse on itself, may be associated with problems such as blood splatter / aerosolization issues, safe storage of preload energy which may fail and activate before desired, loss of accuracy in administering a full dose injection due to residual dead space within the spring compression volume, and / or loss of control over retraction speed which may be associated with pain and patient anxiety.

[0005] Further complicating the syringe market is the increasing demand for prefilled syringe components, e.g. Figure 5A and Figure 5B As shown, it generally includes a syringe body or a "drug packaging delivery system / drug closure container delivery system" (34), a plunger head, a plug or a stopper (36), and a distal seal or cover cap (35) that can be mounted on a Luer-type interface ( Figure 5A The cap 35 is shown in position; Figure 5BThe cap is removed to show the Luer interface 14). Liquid drug may be present in a volume or drug reservoir (40) between the distal seal and the distal end (37) of the plunger tip (36). The plunger tip (36) may comprise a standard butyl rubber material and may be coated with, for example, a biocompatible lubricious coating (e.g., polytetrafluoroethylene ("PTFE")) to facilitate preferred sealing and relative movement characteristics with respect to the associated syringe body structure and materials. Figure 5B The proximal end of the syringe body (34) in the embodiment includes a conventional one-piece syringe flange (38) which is integrally formed with the material of the syringe body (34). The flange (38) is configured to extend radially from the syringe body (34) and can be configured to surround the entire circumference or a portion of the circumference of the syringe body (34). A portion of the flange is referred to as a "truncated flange" and another portion is referred to as a "full flange". The flange is used to grasp the syringe with the fingers to provide support for pushing the plunger for injection. The syringe body (34) preferably includes a translucent material, such as glass or a polymer. In order to form a closed volume within the chamber or reservoir (40) and to facilitate the discharge of the associated fluid through the needle, a plunger head (36) can be disposed within the syringe body (34). The syringe body (34) can define a substantially cylindrical shape (i.e., such that the plunger head 36 having a circular cross-sectional shape can be sealed relative to the syringe body (34)), or can be configured to have other cross-sectional shapes, such as an elliptical shape.

[0006] Such components are ideal because they can be standardized and precisely mass-produced by a small number of manufacturers around the world who are able to meet all of the world’s ever-changing regulations regarding fill, packaging and drug / drug interface material selection and component / component use. However, such simple configurations often do not meet new world standards for single-use, safety, automatic deactivation and needle-stick resistance. As a result, some suppliers have turned to more “vertical” solutions, such as Figure 5C (41) in which the solution attempts to meet all or at least some of the criteria with one solution; due to the attempt to meet these criteria in many different situations, these products may have significant limitations (including those referenced above). Figure 3-4B some limitations described in ) and relatively high storage and usage costs.

[0007] Most injection systems include a needle shield (e.g., a rigid needle shield, a needle cover, etc.) removably coupled to a needle hub and configured to cover the sharp distal end of the needle to minimize accidental needle sticks, protect the needle from mechanical damage, and seal the injection system before use. Existing injection systems are configured to manually remove the needle shield by the user's hand. The needle shield is fixed to the needle hub. The user's hand must apply a large force to remove the needle shield from the needle hub. When removing the needle shield, the user's hand is close to the sharp distal end of the needle. Due to this proximity, the removal of the needle shield can cause an accidental needle stick (e.g., rebound of the hand grasping the needle shield or movement of the hand holding the injection system). When the user applies force to the proximal end of the needle shield to avoid a needle stick, the needle shield may fall off the needle hub and eventually become unwanted trash on the floor of a medical institution. Therefore, a needle shield handling device is needed for more controlled and safe removal of the needle shield from the injection system.

[0008] In addition, for multi-chamber injection systems, pressure may build up in the distal chamber when mixing the drug components prior to injection, wherein the distal end of the needle is sealed by a needle shield. Thus, there is a need for a needle handling device that removably holds the needle shield away but still covers the sharp distal end of the needle to allow venting of the multi-chamber injection system. In particular, there is a need for a needle shield handling device that can utilize the existing and relatively well-controlled supply chain for conventional delivery syringe assemblies. Summary of the invention

[0009] Embodiments relate to injection systems. In particular, the embodiments relate to a needle shield handling device for an injection system.

[0010] In one embodiment, an injection system includes a syringe body having a proximal end and a distal end and defining an interior of the syringe. The system also includes a stop member disposed within the interior of the syringe. The system also includes a plunger member coupled to the stop member and configured to be manipulated to insert the stop member distally into the interior of the syringe relative to the syringe body. In addition, the system includes a needle hub assembly coupled to the syringe body at its distal end and including a needle hub and a needle coupled to the needle hub. In addition, the system includes a needle shield removably coupled to the needle hub over / over the needle. The system also includes a telescopic sleeve coupled to the distal end of the syringe body at least partially over the needle shield.

[0011] In one or more embodiments, the needle hub defines a circumferential groove and the needle shield includes a resilient material configured to interfere with the circumferential groove in the needle hub to prevent the needle shield from being disengaged from the needle hub.

[0012] In one or more embodiments, the telescopic sleeve includes a fixed member and a movable member / movable member configured to telescope relative to each other along the longitudinal axis of the telescopic sleeve. The movable member can be at least partially disposed radially outside the fixed member. The movable member can define an annular space, and the fixed member can be at least partially disposed in the annular space. The telescopic sleeve may include a spring disposed in the annular space radially inside the fixed member. The spring can reduce the force required to remove the needle shield from the needle seat. The spring may not apply a perceptible resistance to a user using the system for an injection.

[0013] In one or more embodiments, the movable member defines a plurality of inwardly extending members configured to interfere / impede the proximal end of the needle shield when the needle shield is coupled to the needle hub. The plurality of inwardly extending members may be configured to apply a distal force from the movable member to the proximal end of the needle shield when the needle shield is coupled to the needle hub. The fixed member may define an outwardly extending flange at its distal end, the movable member may define an inwardly extending flange at its proximal end, and the outwardly extending flange and the inwardly extending flange may be configured to interfere with each other to limit distal movement / movement of the movable member relative to the fixed member. The movable member may define an inclined outer surface configured to facilitate application of a distal force to the movable member of the telescopic sleeve.

[0014] In one or more embodiments, the telescoping sleeve has a retracted configuration and an extended configuration. When the telescoping sleeve is in the retracted configuration, the fixed member and the movable member can substantially overlap each other. When the telescoping sleeve is in the extended configuration, the movable member can move distally relative to the fixed member with minimal overlap between the fixed member and the movable member. The telescoping sleeve can also have a fully retracted configuration. The fixed member can define a side opening, and the movable member can include a latch configured to enter the opening when the telescoping sleeve is in the fully retracted configuration, thereby preventing the movable member from moving distally relative to the fixed member.

[0015] In one or more embodiments, when the telescoping sleeve is in the extended configuration, the distal end of the movable member is substantially aligned with the distal tip of the needle along the longitudinal axis of the system. When the telescoping sleeve is in the extended configuration, the distal end of the movable member can prevent the distal tip of the needle from being visible from the proximal side of the movable member. The distal end of the movable member can be configured to contact the patient's skin substantially simultaneously with the distal tip of the needle during an injection using the system when the telescoping sleeve is in the extended configuration.

[0016] In one or more embodiments, the system further comprises a retaining clip for securing the telescoping sleeve to the needle hub. The movable member may define a plurality of distally extending members configured to removably retain the needle shield away from the distal end of the needle after the needle shield is removed from the needle hub. Each of the plurality of distally extending members may define an inwardly extending rib configured to contact the needle shield after the needle shield is removed from the needle hub.

[0017] In one or more embodiments, the movable member defines a substantially flat distally facing surface. The system may also include a safe return system, such as described herein and in Figures 6A to 7P As shown in , the system is configured to at least partially retract the needle into the syringe body after an injection is completed using the system, so that the distal end of the needle is disposed within the needle seat or within the syringe body.

[0018] In one or more embodiments, the movable member defines a pair of inwardly extending latches that can interfere with the proximal end of the needle shield when the needle shield is coupled to the needle hub. The pair of inwardly extending latches can be configured to apply a distal force from the movable member to the proximal end of the needle shield when the needle shield is coupled to the needle hub.

[0019] In one or more embodiments, the telescopic sleeve has a retracted configuration and an extended configuration. When the telescopic sleeve is in the retracted configuration, the movable member can substantially cover the fixed member. When the telescopic sleeve is in the extended configuration, the movable member can move distally relative to the fixed member.

[0020] In one or more embodiments, the fixed member defines a pair of notches. When the telescoping member is in the retracted configuration or the extended configuration, the pair of inwardly extending latches can be partially disposed in the pair of notches. The pair of inwardly extending latches can be configured to interfere with corresponding proximally facing surfaces at the distal ends of the pair of notches to limit distal movement of the movable member relative to the fixed member.

[0021] In one or more embodiments, the fixed member defines a plurality of inwardly extending pads for contacting an inner surface of the movable member to maintain the telescoping member in the extended configuration. The fixed member may define an inwardly extending rib configured to contact the needle shield after the needle shield is removed from the needle hub.

[0022] In one or more embodiments, the telescoping sleeve can also have a fully retracted configuration. A pair of inwardly extending latches can also be configured to interfere with a proximal surface of the fixed member when the telescoping sleeve is in the fully retracted configuration, thereby preventing the movable member from moving distally relative to the fixed member. When the telescoping sleeve is in the retracted configuration, the distal end of the movable member can be substantially aligned with the distal tip of the needle along the longitudinal axis of the system.

[0023] These and other embodiments of the present invention are described in the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figures 1A to 5C Various aspects of a conventional syringe configuration are shown.

[0025] Fig. 6A and Figure 6B 2 is a perspective view and a longitudinal cross-sectional view showing aspects of a syringe-based dual chamber safety injection system according to some embodiments, with which the needle shield handling device described herein can be used, wherein the distal needle end / needle tip end can be retracted into a protective configuration after use.

[0026] FIG. 7A to FIG. 7P are side and longitudinal cross-sectional views showing aspects of a syringe-based dual chamber safety injection system according to some embodiments, with which the needle shield handling device described herein can be used, and method steps for mixing and injecting using the system.

[0027] Figure 8 and Fig. 9 2 are perspective and side exploded views of a needle shield operator / telescopic member for use with an injection system according to some embodiments.

[0028] Fig.10 is a partially exploded perspective view of a needle shield handling device / telescopic member for use with an injection system according to some embodiments.

[0029] Fig.11 and Fig.12 1 is a longitudinal cross-sectional view and a side view of a needle shield operating device / telescopic member installed on an injection system according to some embodiments.

[0030] Fig.13 and Fig.14 2 is a longitudinal cross-sectional view of a needle shield operating device / telescopic member installed on an injection system according to some embodiments in a retracted configuration and an extended configuration, respectively.

[0031] Fig.15 is a partially removed perspective view of a needle shield handling device / telescopic member for use with an injection system according to some embodiments.

[0032] Fig.16A and Fig. 16B 2 is a longitudinal cross-sectional view and a perspective view of a needle shield operating device / telescopic member mounted on an injection system in an extended configuration according to some embodiments.

[0033] Fig.17A and Fig. 17B2 are longitudinal cross-sectional and perspective views of a needle shield handling device / telescopic member mounted on an injection system in a fully retracted configuration according to some embodiments.

[0034] Fig.18 is an exploded perspective view of a needle shield handling device / telescopic member for use with an injection system according to some embodiments.

[0035] Fig.19 is a partially exploded perspective view of a needle shield handling device / telescopic member for use with an injection system according to some embodiments.

[0036] Fig. 20 , Fig.21 and Fig. 22 Detailed side, longitudinal cross-sectional and side views of a needle shield operator / telescopic member mounted on an injection system according to some embodiments.

[0037] Fig.23 is a longitudinal cross-sectional view of a needle shield handling device / telescopic member mounted on an injection system in a retracted configuration according to some embodiments.

[0038] Fig.24 is a longitudinal cross-sectional view of a needle shield handling device / telescopic member mounted on an injection system in an extended configuration according to some embodiments.

[0039] Fig.25 is a partially removed perspective view of a needle shield handling device / telescopic member for an injection system according to some embodiments.

[0040] Fig.26A , Fig.26B and Fig.28 1 is a longitudinal cross-sectional view, a perspective view, and a perspective view of a needle shield operating device / telescopic member installed on an injection system in an extended configuration according to some embodiments.

[0041] Fig. 27 is a partially removed perspective view of a needle shield handling device / telescopic member according to some embodiments.

[0042] Fig.29A , Fig.29B and Fig.30 1 is a longitudinal cross-sectional view, a perspective view, and a longitudinal partial cross-sectional view of a needle shield operating device / telescopic member installed on an injection system in a fully retracted configuration according to some embodiments.

[0043] Fig.31 is a perspective view of a needle shield handling device / telescopic member for use with an injection system according to some embodiments.

[0044] Fig.32 is a side view of a needle shield handling device / telescopic member installed on an injection system according to some embodiments.

[0045] Fig.33 and Fig.34 2 is a longitudinal cross-sectional view of a needle shield operating device / telescopic member installed on an injection system according to some embodiments in a retracted configuration and an extended configuration, respectively.

[0046] Fig.35A , Fig.35B and Fig.35C 1 are longitudinal cross-sectional views of a needle shield operating device / telescopic member mounted on an injection system in short-range, mid-range, and long-range extended configurations, respectively, according to some embodiments.

[0047] In order to better understand how to obtain the above and other advantages and purposes of various embodiments, the embodiments are described in more detail with reference to the accompanying drawings. It should be noted that the drawings are not drawn to scale, and elements of similar structure or function are represented by similar reference numerals throughout the text. It should be understood that these drawings only depict certain illustrated embodiments and should not be considered to limit the scope of the embodiments. DETAILED DESCRIPTION

[0048] Exemplary dual chamber safety syringe system for use with a needle cover operating device

[0049] refer to Figure 6A-6B, showing a perspective view and a longitudinal cross-sectional view of a dual-chamber safety injection system, a conventional pre-filled syringe body (34) is provided with conventional proximal stopper and distal stopper (32, 36). The proximal stopper and distal stopper (32, 36) together with the syringe body (34) define a proximal drug chamber and a distal drug chamber (40, 42). The proximal stopper and distal stopper (32, 36) block the proximal and distal ends of the proximal drug chamber (40). The distal stopper (36) blocks the proximal end of the distal drug chamber (42). A needle hub assembly (606) is provided at the distal end of the distal drug chamber (42), and a needle shield (63) is installed for storage. The dual chamber safety injection system controls the transfer of a first drug component from a proximal drug chamber (40) to a distal drug chamber (42), and the expulsion of a mixed / combined drug from the distal drug chamber (42) to the distal side, which is affected by the user sequentially inserting a plunger member (44) to different degrees relative to a syringe body (34). The plunger member (44) includes a proximal stop member (32), a plunger housing member (69) and a plunger manipulation interface (128). The first drug component (252) located in the proximal drug chamber (40) can be a liquid, such as a water-based or oil-based drug solution, a gel, or the first drug component can be a diluent for mixing with a second drug component (254) in the distal drug chamber (42). The second drug component (254) in the distal drug chamber (42) can be a drug in a dry form, such as a powder, microsphere, emulsion, lyophilized or freeze-dried drug, or a cake-like solid drug.

[0050] The dual chamber safety injection system has a staked needle / staked needle configuration wherein, when presented to the user, the needle assembly, including the needle hub assembly (606), the needle distal end / tip (48), the needle engagement member, and the needle proximal end (50) are mounted in position, ready for injection after removal of the needle shield (63), which may include an elastomeric sealing material on its interior surface to engage with the needle distal end (48) or the distal housing portion (610) during storage. Alternatively, the needle shield (63) may include a vent (not shown) for allowing pressure generated by the transfer and mixing of the drug components to escape from the interior of the syringe body (34) while preventing contaminants from entering the syringe body (34). Although the staked needle is depicted as being mounted in position, the staked needle may be removably coupled to the syringe body (34) using a Luer interface (not shown), with the proximal end (50) of the needle member extending through the Luer interface and into the distal drug chamber (42). Figures 6A-7P In the embodiment shown, the majority of the safety needle retraction hardware is located within the plunger housing (69).

[0051] The dual chamber safety injection system has a staked needle configuration wherein, when presented to the user, the needle assembly, including the needle spine assembly ("needle") (76) and the needle hub assembly (606)) is mounted in position, ready for injection after removal of the needle shield (63), which may include a resilient sealing material on its interior surface to engage with the needle distal end (78) and / or distal housing portion during storage. Alternatively, the needle shield (63) may include a vent (not shown) for allowing pressure generated by the transfer of the first drug component / diluent (252) to escape from the interior of the syringe body (34) while preventing contaminants from entering the syringe body (34). Although the staked needle is depicted as being mounted in position, the staked needle may be removably coupled to the syringe body (34) using a Luer slip or Luer lock interface (not shown), with the proximal end (50) of the needle member extending through the Luer interface and into the distal chamber (42). Alternatively, the needle may be fixedly or removably mounted on a flange on the cartridge body rather than on the syringe. exist Fig. 6A and Figure 6B In the embodiment shown, the majority of the safety needle retraction hardware is located within the plunger housing (69).

[0052] refer to Figures 7A-7P , showing aspects of a configuration that facilitates injection of a multi-component drug and retraction of the needle into the body of the syringe, wherein two or more drug components are combined immediately prior to delivery to a patient to form an injectable combination or solution. In one variation, a liquid first drug component / diluent (252) may be combined with a substantially non-liquid second drug component (254) shortly before injection, the second drug component (254) being, for example, a powdered form of a drug formulation, such as a lyophilized or freeze-dried drug component. Reference herein Figures 7A-7P The described construction involves a dual chamber configuration in which two or more chambers within the same syringe body (34) are used to transport, mix and inject an injection solution.

[0053] refer to Fig. 7A and Figure 7B The proximal and distal drug chambers (40, 42) are formed by a distal stopper (36) located between two parts inside the syringe body (34), so that the distal drug chamber (42) contains an air or gas gap and a non-liquid drug (254); the proximal drug chamber (40) located on the opposite side of the distal stopper (36) contains a liquid diluent (252) which is contained proximally by the proximal stopper (32). The liquid diluent (252) is a first component of the drug, and the non-liquid drug (254) is a second component of the drug.

[0054] refer to Figure 7C and Fig.7D, the various components of the needle hub assembly (here a so-called "studded / studded / studded" needle hub assembly (606) is shown, but other needle assemblies described below, including Luer couplings and studded configurations, may also be used). For example, Fig. 7A As shown, the lug feature (258) is configured to help connect the needle hub assembly (606) to the needle shield (63). A small O-ring can be used as a sealing member (260) around the needle shaft, while a larger O-ring can be used as a sealing member (262) at the syringe body (34) / needle hub assembly (606) interface. Optionally, the small O-ring (260) and the large O-ring (262) can be combined into a single seal that performs both O-ring sealing functions. In addition, the small O-ring (260) can be used to seal around the needle shaft and the syringe body (34).

[0055] The needle includes multiple (e.g., four) proximal openings / ports (270) configured to allow liquid diluent to enter and exit from a distally positioned intermediate opening / orifice (266); see, e.g., above, FIG. 6N and Figure 7H Under the conditions described, the lumen plug (268) blocks the needle lumen to form a flow path from the proximal opening (270) to the middle opening (266). The needle also includes a distal opening (264) on the side of the lumen plug (268) opposite the middle opening (266). The distal opening (264) is fluidly coupled to the needle distal end (48) through the needle to inject liquid into the patient.

[0056] refer to Fig. 7E The proximal harpoon interface (84) is configured to continuously penetrate the proximal stop member and the distal stop member (32, 36) and engage with a coupling feature structure (e.g., at the end of the plunger member (44) Figure 7N and Figure 7P Element (712) in FIG. 1 shows a needle retaining feature structure) connection. Figure 7F A spike-type harpoon coupling interface (85) is shown, which is configured to continuously pierce the proximal stop member and the distal stop member (32, 36) and couple with a coupling feature structure in the plunger member (44) to at least partially retract the needle member into the plunger member (44) after an injection into a patient.

[0057] Fig. 7A , Figure 7B and Figure 7G-7P A series of actions of the injection procedure using the above-mentioned dual-chamber safety injection system are shown. Fig. 7A and Figure 7B, the injection assembly is in a stable configuration in which it can be transported or brought to an injection patient care location; the first drug component / liquid diluent (252) is isolated from the second non-liquid drug component (254), and the two are located on opposite sides of the distal stop member (36) within the syringe body.

[0058] Figure 7G and Figure 7H An initial insertion movement of the plunger member (44) is shown, causing the distal stop member (36) and the proximal stop member (32) to advance together relative to the syringe body (34). Figure 7H , with advancement sufficient to cause the proximal end (50) of the needle assembly to pierce the distal stop member (36), a fluid path is formed between the two previously isolated chambers (40, 42) of the syringe body (34), such that a liquid first drug component (252) in the proximal drug chamber (40) can flow into at least one proximal opening (270), through the delivery tube (46) and out of the more distal intermediate opening (266) to reach a non-liquid second drug component (254) in the distal drug chamber (42).

[0059] Fig.7I and Figure 7J It is shown that with further insertion, until the stop members (36, 32) are in close proximity to one another, the liquid first drug component / diluent (252) has moved into the distal drug chamber (42) to join the non-liquid second drug component (254). Figure 7K and Figure 7L Over time and / or manual agitation, the liquid first drug component / diluent (252) and the previously non-liquid second drug component (254) are shown mixing to form a mixed drug solution (272).

[0060] In some embodiments, particularly when a lyophilized non-liquid second drug component is used, a mixed drug solution (272) may be formed with minimal or no agitation or over time. In another embodiment, particularly for drugs held in suspension or emulsified drugs, vigorous shaking may be required to promote mixing. In the case of vigorous shaking, it is useful for the user to be able to remove their thumb from the plunger operating interface (128). During the transfer of the liquid first drug component (252) from the proximal drug chamber (40, 42) to the distal drug chamber (42), pressure may accumulate in the distal drug chamber (42). This pressure acts on the proximal stop member and the distal stop member (32, 36) to prevent the stop member from moving. If the user does not restrain the plunger member (44) with their thumb, the increase in pressure may also cause the stop member (32, 36) and the plunger operating interface (128) to move proximally. A mixing configuration latch / latch or "mixing claw" in the plunger member (44) can be used to provide resistance to movement of the plunger manipulation interface (128) due to pressure buildup and allow the user to release their thumb from the plunger manipulation interface (128) to shake or mix the medication. The mixing claw can also provide an audible and / or tactile indication that the transfer of the liquid first medicament component (252) has been completed. The distal medicament chamber (42) can also include a stirring device that assists in mixing the medicament components.

[0061] When the assembly is ready to inject the mixed solution (272), the needle shield (63) can be removed and the patient can be injected with the needle distal end (48) exposed by pressing / inserting the plunger member (44) and the associated stop member (36, 32), as shown in FIG. Figure 7M and Figure 7N See Fig.7O and Figure 7P As the plunger member (44) and the associated stop members (32, 36) are fully depressed / inserted, the sharp needle distal end / needle tip (48) can automatically retract at least partially through the distal stop member and the proximal stop member (36, 32) to a safe position within the syringe body (34), the needle seat assembly (606), or at least partially retract into the plunger member (44).

[0062] The needle shield handling device described herein may also be used in a multi-chamber injection system.

[0063] Exemplary needle shield operation and needle hiding device for injection system

[0064] Figure 8 and Fig. 9The needle shield handling device (800) is shown for use with an injection system (100) before the needle shield handling device (800) is coupled to the injection system (100), according to some embodiments. Although the injection system (100) is a single chamber injection system, the needle shield handling device (800) can be used with a multi-chamber injection system, such as Figures 6A to 7P Those systems shown in without any modifications.

[0065] The injection system (100) includes an injection system body (34) having a needle hub assembly (606) including a needle hub (610) and a needle (620) coupled to the needle hub (610). The injection system (100) also includes a needle shield (63) (see Fig. 9 ), when the injection system (100) is in the transport / storage configuration, the needle shield (63) is disposed on the sharp distal end (622) of the needle (620). The needle shield (63) includes an elastic material (632) configured to interfere with a circumferential groove (612) defined by the needle hub (610) to secure the needle shield (63) to the needle hub (610). The elastic material (632) also protects the needle (620) from mechanical damage and seals the injection system (100) prior to use. The needle shield (63) minimizes accidental needle sticks during use.

[0066] like Fig. 9 As shown, the needle shield operating system (800) is a telescopic / telescopic sleeve (800). The telescopic sleeve (800) includes a fixed member (810) and a movable member (850), which are configured to telescope relative to each other to change the length of the telescopic sleeve (800). During the assembly of the telescopic sleeve (800) to the injection system (100), the fixed member (810) is connected to the needle seat (610) and the injection system body (34) using a retaining clip (890) (see Fig.10 ). By comparison Fig. 9 and Fig.10 It can be seen that the telescoping sleeve (800) is mounted to the injection system (100) by sliding the telescoping sleeve (800) over the needle shield (63) and securing the telescoping sleeve (800) with a retaining clip (890).

[0067] Fig.11 and Fig.12 A telescopic sleeve (800) is shown mounted on an injection system (100). Fig.11 As shown, the movable member (850) defines an annular space (852) in which the distal portion of the fixed member (810) is disposed. The outer portion of the movable member (850) is disposed radially outward of the fixed member (810).

[0068] The telescoping member (800) further includes a spring (892) disposed in the annular space (852) defined by the movable member (850). The spring (892) reduces the force required to remove the needle shield from the needle hub (610). At the same time, the spring (892) does not exert a resistance that is noticeable to a user performing an injection using the injection system (100).

[0069] Fig.13 and Fig.14 Shown in the retracted configuration ( Fig.13 ) and extended configuration ( Fig.14 ) of the telescopic member (800). Fig.13 In the retracted configuration shown, the fixed and movable members (810, 850) substantially overlap each other. Fig.14 In the extended configuration shown, movable member (850) is moved distally relative to fixed member (810) such that overlap between fixed member (810) and movable member (850) is minimized. Telescoping member (800) is relatively short in the retracted configuration compared to the extended configuration.

[0070] The fixed member (810) defines an outwardly extending flange (812) at its distal end, and the movable member (850) defines a corresponding inwardly extending flange (854) at its proximal end. The outwardly extending flange (812) and the inwardly extending flange (854) are configured to interfere with each other to limit the distal movement of the movable member (850) relative to the fixed member (810), such as Fig.14 shown.

[0071] The movable member (850) further defines a plurality of inwardly extending members (856) configured to interfere with the proximal end (634) of the needle shield (63) when the needle shield (63) is coupled to the needle hub (610). Thus, the plurality of inwardly extending members (856) are configured to apply a distally directed force from the movable member (850) to the proximal end (634) of the needle shield (63), thereby removing the needle shield (63) from the needle hub (610). The distally directed force transmitted from the movable member (850) through the plurality of inwardly extending members (856) is sufficient to overcome the resistance between the elastic material (632) of the needle shield (63) and the outer surface of the needle hub (620 / 610), including the groove (612) formed therein.

[0072] The movable member (850) also has an inclined outer surface (858) configured to facilitate a user to apply a distally directed force to the movable member (850) using the fingers and thumb of one hand. Fig.12As shown, the inclined outer surface (858) may have arrows (860) formed thereon to guide the user to remove the needle shield (63) using the needle shield handling device / telescopic member (800). These inclined outer surfaces (858) are much larger than the small needle shield (63) and are therefore easier to operate than the latter, making it easier to remove the needle shield (63) using the inclined outer surface (8580) of the telescopic member (800). Because the multiple inwardly extending members (856) limit the travel of the needle shield to along the axis of the needle (622), the needle is better protected from bending or damage. Therefore, this also makes it easier for the user to remove the needle shield because the device controls the direction for them, so they are less constrained in controlling the direction of needle shield removal. In addition, when the needle shield is removed, the needle is surrounded by the movable member (850). This makes the removal of the needle shield safer and easier because the user's hand does not contact the needle during removal and prevents the needle from bending or damage.

[0073] Fig.14 The telescoping member (800) is shown in an extended configuration. The plurality of inwardly extending members (856) have pushed the needle shield (63) distally away from the needle seat (610). At the same time, the elastic material (632) of the needle shield (63) moves away from the sharp distal end (622) so that the distal end (622) is no longer enclosed by the elastic material (632). In this way, any overpressure accumulated in the injection system body (34) can be exhausted through the needle (620). Maintaining the injection system (100) in a vertical position during exhaust avoids loss of injectable fluid while allowing gas and pressure to escape.

[0074] Fig.15 A plurality of distally extending members (862) are shown defined by the movable member (850). Each distally extending member (862) defines an inwardly extending compression rib (864) configured to extend when the telescoping member (800) is in a position such as Fig.15 The needle shield (63) is removably retained in the extended configuration shown. After optional venting, the user can gently pull the needle shield (63) from the squeeze rib (864) of the movable member (850) to remove the needle shield (63) from the injection system (100) in preparation for injection.

[0075] Fig.16A and Fig. 16B The injection system (100) is shown ready for injection after the needle shield (63) is removed, with the telescoping member (800) in the extended configuration. As described herein, the spring (892) does not exert a perceptible / appreciable resistance to a user using the injection system (100) to perform an injection, with the telescoping member (800) in the extended configuration.

[0076] The distal end of the movable member (850) forms a substantially flat distal surface (866). In the extended configuration, the distal surface (866) of the movable member (850) is substantially aligned with the distal end (622) of the needle (620) along the longitudinal axis of the injection system (100). In this way, the sharp distal end (622) of the needle (620) is not visible from the proximal side of the movable member (850). This reduces the anxiety of the patient receiving the injection by obscuring the needle (620) and its sharp distal end (622) from the patient's field of vision. In addition, the distal surface (866) of the movable member (850) contacts the injection site completely surrounding the sharp distal end (622) of the needle (620) at the same time or slightly earlier than the latter. In this way, by providing a different tactile sensation to the nerves around the injection site, the contact around the injection site reduces / obscures the pain caused by the injection of the sharp distal end (622) of the needle (620). The injection angle of the injection system (100) with the telescoping member (800) installed can be optimally limited to substantially orthogonal / perpendicular. Substantially orthogonal includes deviations from orthogonal by up to about 15°.

[0077] Fig.17A and Fig. 17B The telescopic member (800) is shown after being injected using the injection system (100) with the telescopic member (800) installed. During the injection process, the movable member (850) is pushed proximally relative to the fixed member (810) until the telescopic member (800) is in the Fig.17A and Fig. 17B The fully retracted configuration shown. The fixed member (810) defines a plurality of side openings (814), and the movable member (850) defines a corresponding plurality of latches (868). When the telescopic member (800) is in the fully retracted configuration, the latches (868) on the movable member (850) extend into the side openings (814) in the fixed member (810) and restrict the movable member (850) from moving distally relative to the fixed member (810). In this way, the telescopic member (800) in the fully retracted configuration is referred to as "locked" because it can no longer be telescoped to change its length. When the telescopic member (800) is "locked" in the fully retracted configuration, the combined injection system (100) and telescopic member (800) have a smaller footprint for waste disposal. This allows more used injection devices to be placed in a "sharp" container of a specific volume.

[0078] The extended configuration of the telescopic member (800) Fig.14 , Fig.16A and Fig. 16B ) is different from expandable / expandable needle shields (e.g. Figure 3In order to prevent accidental needle sticks after injection, the expandable needle shield (22) is released from the proximal / retracted configuration and "locked" in the distal / extended configuration, so that the expanded needle shield (22) can no longer return to the proximal / retracted position to cover the needle (8) after injection. In this way, by providing a different tactile sensation to the nerves around the injection site, the expandable needle shield (22) will not obscure the patient's view of the needle penetrating the skin, nor will it reduce / obscure the pain caused by the sharp distal injection of the needle (22). On the other hand, before injection, the telescopic member (800) is expanded to the extended configuration ( Fig.14 , Fig.16A and Fig. 16B ), and is "unlocked" in the extended configuration to allow injection. In this way, the telescopic member (800) obscures the patient's observation of the needle (620) piercing the skin by providing a different tactile sensation to the nerves around the injection site, and reduces / obscures the pain of the injection by the sharp distal end (622) of the needle (620). After the injection, the telescopic member (800) is "locked" in the fully retracted configuration ( Fig.17A and Fig. 17B ), in which configuration, the distal end (622) of the needle (620) is exposed.

[0079] Fig.17A and Fig. 17B After injection, telescoping member (800) is shown not covering distal end (622) of needle (620). However, injection system (100) may be implemented such as Figures 6A to 7P The needle retraction system shown in the figure is used to provide a safe injection system together with the needle shield management device / telescopic member (800). Although the needle shield operation device / telescopic member (800) is described as using a distally directed force applied to the movable member (850) to facilitate the removal of the needle shield (63) from the needle hub (610), the user can remove the shield (63) from the needle hub (610) by pulling the needle shield (63) even when the telescopic member (800) is in the retracted configuration (see Fig.11 and Fig.12 ), the user can also access the needle shield (63). Once the user removes the needle shield (63), the movable member (850) automatically springs forward to hide the distal end (622) of the needle (620) because the removal of the needle shield (63) releases the spring (892) from its compressed state.

[0080] Fig.18The needle shield handling device (1800) is shown being used with an injection system (100) before the needle shield handling device (1800) is coupled to the injection system (100) according to some embodiments. Although the injection system (100) is a single chamber injection system, the needle shield handling device (1800) can be used with a multi-chamber injection system, such as Figures 6A to 7P The multi-chamber injection system shown in FIG. 1 is a multi-chamber injection system that can be used in combination with a conventional injection system without any modifications.

[0081] The injection system (100) includes an injection system body (34) having a needle hub assembly (606) including a needle hub (610) and a needle (620) coupled to the needle hub (610). The injection system (100) also includes a needle shield (63) (see Fig.19 ), when the injection system (100) is in the transport / storage configuration, the needle shield (63) is disposed on the sharp distal end (622) of the needle (620). The needle shield (63) includes an elastic material (632) configured to interfere with the circumferential groove (612) defined by the needle hub (610) to secure the needle shield (63) to the needle hub (610). The elastic material (632) also protects the needle (620) from mechanical damage and seals the injection system (100) prior to use. The needle shield (63) minimizes accidental needle sticks during use.

[0082] and Figure 8 Similar to the needle shield operating system (800) shown in FIG. 17 , the needle shield operating system (1800) is a telescopic sleeve (1800). The telescopic sleeve (1800) includes a fixed member (1810) and a movable member (1850) which are configured to be telescopic relative to each other to change the length of the telescopic sleeve (1800) (see FIG. Fig.21 During assembly of the telescoping sleeve (1800) to the injection system (100), the securing member (1810) is coupled to the needle hub (610) and the injection system body (34) using a retaining clip (1890) (see Fig.19 ). By comparison Fig.18 and Fig.19 It can be seen that the telescoping sleeve (1800) is mounted to the injection system (100) by sliding the telescoping sleeve (1800) over the needle shield (63) and securing the telescoping sleeve (1800) with a retaining clip (1890).

[0083] Figure 20 to Figure 22 A telescopic sleeve (1800) is shown mounted on the injection system (100). Fig.21 As shown, the movable member (1850) is disposed radially outside the fixed member (1810).

[0084] Fig.23 and Fig.24 shows that in the retracted configuration ( Fig.23 ) and the extended configuration ( Fig.24 ) of the telescopic member (1800). Fig.23 In the retracted configuration shown, movable member (1850) substantially covers fixed member (1810). Fig.24 In the extended configuration shown, movable member (1850) has moved distally relative to fixed member (1810) relative to the retracted configuration. Telescoping member (1800) is relatively shorter in the retracted configuration than in the extended configuration.

[0085] The movable member (1850) further defines a pair of inwardly extending members / latches (1856) configured to interfere with the proximal end (634) of the needle shield (63) when the needle shield (63) is coupled to the needle hub (610). Thus, the pair of inwardly extending members / latches (1856) are configured to apply a distally directed force from the movable member (1850) to the proximal end (634) of the needle shield (63) to remove the needle shield (63) from the needle hub (610). The distally directed force transmitted from the movable member (1850) through the pair of inwardly extending members / latches (1856) is sufficient to overcome the resistance between the elastic material (632) of the needle shield (63) and the outer surface of the needle hub (620 / 610), including the groove (612) formed therein.

[0086] The movable member (1850) further defines an inclined outer surface (1858) configured to facilitate a user applying a distal force to the movable member (1850) using the fingers and thumb of one hand. Fig. 22As shown, the angled outer surface (1858) may have arrows (1860) formed thereon to guide the user in removing the needle shield (63) using the needle shield handling device / telescopic member (1800). These angled outer surfaces (1858) are much larger than the small needle shield (63) and are therefore easier to operate than the latter, thereby making it easier to remove the needle shield (63) using the angled outer surface (1858) of the telescopic member (1800). Because the multiple inwardly extending members (1856) limit the travel of the needle shield to along the axis of the needle (622), the needle is better protected from bending or damage. Therefore, this also makes it easier for the user to remove the needle shield (63) because the user is less constrained in controlling the direction of needle shield (63) removal because the needle shield management device / telescopic member (1800) controls the direction of needle (63) removal. Furthermore, when the needle shield (63) is removed, the distal end (622) of the needle (620) is surrounded by the movable member (850). This makes the removal of the needle shield (63) safer and easier because the user's hands are protected from contact with the needle (620) during the removal process and the needle (620) is protected from bending or damage.

[0087] Fig.24 The telescoping member (1800) is shown in an extended configuration. The pair of inwardly extending members / grips (1856) have pushed the needle shield (63) distally away from the needle seat (610). At the same time, the elastic material (632) of the needle shield (63) moves away from the sharp distal end (622) so that the distal end (622) is no longer enclosed by the elastic material (632). In this way, any overpressure accumulated in the injection system body (34) can be exhausted through the needle (620). Maintaining the injection system (100) in a vertical position during exhaust avoids loss of injectable fluid while allowing gas and pressure to escape.

[0088] Fig.25 A plurality of inwardly extending pads / bumps (1864) are shown defined by the fixed member (1810). The plurality of inwardly extending pads (1864) are configured to extend when the telescoping member (1800) is in a position such as Fig.24 and Fig.25 The needle shield (63) is removably retained in the extended configuration shown. After optional venting, the user can gently pull the needle shield (63) from the inwardly extending spacer (1864) of the movable member (1850) to remove the needle shield (63) from the injection system (100) in preparation for injection.

[0089] Fig.26A , Fig.26B , Fig. 27 and Fig.28The injection system (100) is shown ready for injection after the needle shield (63) is removed, with the telescoping member (1800) in an extended configuration. The fixed member (1810) defines a pair of longitudinal notches (1816) extending to its distal end and corresponding to a pair of inwardly extending members / catches (1856) defined by the movable member (1850). Fig.26A , Fig.26B and Fig. 27 As shown, the pair of inwardly extending members / catches (1856) are configured to interfere with a proximally facing surface (1818) of the fixed member (1810) that defines the distal end of the corresponding longitudinal slot (1816) to limit the distal movement of the movable member (1850) relative to the fixed member (1810). When the telescoping member (1800) is in the extended configuration, the plurality of ramps / bosses (1820) extending outwardly from the fixed member (1810) increase the friction fit between the fixed member and the movable member (1810, 1850). Any resistive friction between the fixed member and the movable member (1810, 1850) is not noticeable to a user performing an injection using the injection system (100) with the telescoping member (1800) in the extended configuration.

[0090] The distal end of the movable member (1850) forms a substantially flat distal surface (1866). In the extended configuration, the distal surface (1866) of the movable member (1850) is away from the distal end (622) of the needle (620) along the longitudinal axis of the injection system (100). In this way, the sharp distal end (622) of the needle (620) is not visible from the proximal side of the movable member (1850). This reduces the anxiety of the patient receiving the injection by obscuring the needle (620) and its sharp distal end (622) from the patient's field of vision. In addition, the distal surface (1866) of the movable member (1850) completely surrounds the injection site and makes contact slightly earlier than the sharp distal end (622) of the needle (620). In this way, by providing a different tactile sensation to the nerves around the injection site, the contact around the injection site reduces / obscures the pain caused by the injection of the sharp distal end (622) of the needle (620). The injection angle of the injection system (100) installed with the telescoping member (1800) can be optimally limited to being substantially orthogonal. Substantially orthogonal includes deviations from orthogonal by up to 15° to 30°.

[0091] Although the needle shield handling device / telescopic member (1800) is described as utilizing a distally directed force applied to the movable member (1800) to facilitate removal of the needle shield (63) from the needle hub (610), the user may remove the needle shield (63) from the needle hub (610) by pulling on the needle shield (63), and the user may access the needle shield (63) when the telescopic member (1850) is in the retracted configuration (see Fig.23 Even if the user removes the needle shield (63), the movable member (1850) still covers the distal end (622) of the needle (620), thereby protecting the user's hands when the user chooses to remove the needle shield (63) by pulling.

[0092] Fig.29A , Fig.29B and Fig.30 The telescopic member (1800) is shown after injection using the injection system (100) with the telescopic member (1800) installed. During the injection process, the movable member (1850) is pushed proximally relative to the fixed member (1810) until the telescopic member (1800) is in the Fig.29A , Fig.29B and Fig.30 18. The fully retracted configuration shown. When the telescopic member (1800) is in the fully retracted configuration, a pair of inwardly extending members / catches (1856) defined by the movable member (1850) have moved proximally out of the pair of longitudinal slots (1816) (guided by the ramps built into each of the inwardly extending members / catches (1856)). The pair of inwardly extending members / catches (1856) interfere with the proximally facing end surface (1822) of the fixed member (1810) and restrict the movable member (1850) from moving distally relative to the fixed member (1810). In this way, the telescopic member (1800) in the fully retracted configuration is referred to as being "locked" because it can no longer be extended to change its length. When the telescopic member (1800) is "locked" in the fully retracted configuration, the combined injection system (100) and telescopic member (1800) have a smaller footprint for disposal of waste. This allows more used injection devices to be placed in a specific volume "sharps" container.

[0093] The extended configuration of the telescopic member (1800) Fig.26A , Fig.26B , Fig. 27 and Fig.28 ) is different from the expandable needle shield (e.g. Figure 3 1800) is an expanded configuration of the tubular shield member (22) shown. To prevent accidental needle sticks after injection, the expandable needle shield (22) is released from the proximal / retracted configuration and "locked" in the distal / extended configuration, so that the expandable needle shield (22) can no longer return to the proximal / retracted position to cover the needle (8) after injection. In this way, by providing a different tactile sensation to the nerves around the injection site, the expandable needle shield (22) will not block the patient's view of the needle penetrating the skin, nor will it reduce / obscure the pain caused by the sharp distal injection of the needle (22). On the other hand, before injection, the telescopic member (1800) is expanded to the extended configuration ( Fig.26A , Fig.26B , Fig. 27 and Fig.28 ), and is "unlocked" in the extended configuration to allow injection. In this way, the telescopic member (1800) obscures the patient's observation of the needle (620) piercing the skin by providing a different tactile sensation to the nerves around the injection site, and reduces / obscures the pain caused by the sharp distal end (622) of the needle (620) during injection. After the injection, the telescopic member (1800) is "locked" in the fully retracted configuration ( Fig.29A , Fig.29B and Fig.30 ), in which configuration, the distal end (622) of the needle (620) is exposed.

[0094] Fig.29A , Fig.29B and Fig.30 After injection, telescoping member (1800) is shown not covering distal end (622) of needle (620). However, injection system (100) may be implemented such as Figures 6A to 7P , to provide a safe injection system in conjunction with the needle shield management device / telescopic member (1800). Although the needle shield management device / telescopic member (1800) is described as utilizing a distally directed force applied to the movable member (1850) to facilitate removal of the needle shield (63) from the needle hub (610), the user can remove the shield (63) from the needle hub (610) by pulling on the needle shield (63), even when the telescopic member (1800) is in the retracted configuration (see Fig. 20 and Fig.21 ), the user can also access the needle shield (63). However, when the telescopic member (1800) is in the retracted configuration, most access to the needle shield (63) is blocked by the movable member (1850), thereby preventing the user from pulling the needle shield (63) away and encouraging the user to use the telescopic member (1800) to remove the needle shield (63). Although the user can manually remove the needle shield (63) with their hands, when the movable member (1850) is in the retracted configuration (see Fig. 20 and Fig.21 ), movable member (1800) still covers the distal end (622) of needle (620).

[0095] Fig.31 The needle shield handling device (3100) is shown for use with the injection system (100) before the needle shield handling device (3100) is coupled to the injection system (100) according to some embodiments. Although the injection system (100) is a single chamber injection system, the needle shield handling device (3100) can be used in a multi-chamber injection system, such as Figures 6A to 7P Those systems shown in without any modifications.

[0096] The injection system (100) includes an injection system body (34) having a needle hub assembly (606) including a needle hub (610) and a needle (620) coupled to the needle hub (610). The injection system (100) also includes a needle shield (63) disposed over the sharp distal end of the needle (620) when the injection system (100) is in a transport / storage configuration. The needle shield (63) minimizes accidental needle sticks during use.

[0097] and Figure 8 To Figure 17 and Figures 18 to 30 The needle shield operating system (3100) is similar to the needle shield operating system (800, 1800) shown in the figure. The needle shield operating system (3100) is a telescopic sleeve (3100). The telescopic sleeve (3100) includes a fixed member (3110) and a movable member (3150), which are configured to be telescopic relative to each other to change the length of the telescopic sleeve (3100) (see Fig.33 and Fig.34 ). By comparison Fig.31 and Fig.32 It can be seen that the telescoping sleeve (3100) is mounted to the injection system (100) by sliding the telescoping sleeve (3100) over the needle shield (63) and securing the telescoping sleeve (3100) with a retaining clip (not shown).

[0098] Fig.33 and Fig.34 Shown in the retracted configuration ( Fig.33 ) and the extended configuration ( Fig.34 ) of the telescopic member (3100). Fig.33 In the retracted configuration shown, movable member (3150) substantially covers a middle portion of fixed member (3110). Fig.34 In the extended configuration shown, movable member (3150) has moved distally relative to fixed member (3110) relative to the retracted configuration. Telescoping member (3100) is relatively shorter in the retracted configuration compared to the extended configuration.

[0099] Fig.33 and Fig.34 It is also shown that the distal end of the movable member (3150) defines a dome (3151) in which a rotating cup (3153) is disposed. When the telescopic member (3100) is mounted on the rotating cup, the rotating cup helps the injection system (100) achieve an injection angle of up to 30° from the orthogonal direction, and even an injection angle of up to 45° from the orthogonal direction.

[0100] Fig.33 and Fig.34Also shown is movable member (3150) comprising an adjustment dial / adjustment dial (3155) configured to allow a user to set the needle length. Fig.35A , Fig.35B and Fig.35C A needle shield handling device / telescopic member (3100) is shown mounted on an injection system (100) according to some embodiments, wherein the telescopic member (3100) is "locked" in the respective short-range, mid-range, and long-range fully retracted configurations. Rotating the adjustment dial (3155) adjusts the relative position of the movable member (3150) and the fixed member (3110) to adjust the needle length before or after removing the needle shield. For example, Fig.35A A needle length of 0.5 inches is shown, Fig.35B shows a needle length of 0.75 inches, while Fig.35C A needle length of 1.0 inch is shown.

[0101] The combined injection system (100) and the telescoping member (3100) have a smaller waste disposal footprint when the telescoping member (3100) is "locked" in the fully retracted configuration. This allows more of the used injection device to be placed in a specific volume of the "sharps" container.

[0102] like Fig.34 As shown, the distal end of the rotating cup (3153) of the movable member (3150) forms a substantially flat distal surface (3166). Fig.34 In the extended configuration shown, the distal surface (3166) of the rotating cup (3153) of the movable member (3150) is substantially aligned with the distal end (622) of the needle (620) along the longitudinal axis of the injection system (100). In this way, the sharp distal end (622) of the needle (620) is not visible from the proximal side of the movable member (3150). This reduces the anxiety of the patient receiving the injection by obscuring the needle (620) and its sharp distal end (622) from the patient's field of vision. In addition, the distal surface (3166) of the rotating cup (3153) of the movable member (3150) contacts the injection site completely surrounding the sharp distal end (622) of the needle (620) at the same time or slightly earlier than the latter. In this way, by providing a different tactile sensation to the nerves around the injection site, the contact around the injection site reduces / obscures the pain caused by the injection of the sharp distal end (622) of the needle (620).

[0103] The extended configuration of the telescopic member (3100) Fig.34 ) is different from the extended configuration of the expandable needle shield, e.g. Figure 3The tubular shield member (22) is shown. To prevent accidental needle sticks after injection, the expandable needle shield (22) is released from the proximal / retracted configuration and "locked" in the distal / extended configuration, so that the expandable needle shield (22) can no longer return to the proximal / retracted position to cover the needle (8) after injection. In this way, by providing a different tactile sensation to the nerves around the injection site, the expandable needle shield (22) will not block the patient's view of the needle penetrating the skin, nor will it reduce / obscure the pain caused by the sharp distal injection of the needle (22). On the other hand, before injection, the telescopic member (3100) is expanded to the extended configuration ( Fig.34 ), and is "unlocked" in the extended configuration to allow injection. In this way, the telescopic member (3100) obscures the patient's observation of the needle (620) piercing the skin by providing a different tactile sensation to the nerves around the injection site, and reduces / obscures the pain caused by the sharp distal end (622) of the needle (620) during injection. After the injection, the telescopic member (3100) is "locked" in the fully retracted configuration ( Fig.35A , Fig.35B and Fig.35C ), in which the distal end (622) of the needle (620) is exposed to varying degrees depending on the needle length selected by the user by rotating the adjustment dial (3155).

[0104] Fig.35A , Fig.35B and Fig.35C After injection, telescoping member (3100) is shown not covering distal end (622) of needle (620). However, injection system (100) may be implemented such as Figures 6A to 7P The needle retraction system shown in , together with the needle cover management device / telescopic member (3100) provides a safe injection system.

[0105] Although the above embodiments include single-chamber and dual-chamber (safety) injection systems, the scope of the claims also includes other multi-chamber injection systems with or without safety injection systems. For multi-chamber safety injection systems with more than two chambers, more than two stopper members are inserted into the injection system body (e.g., syringe body, cartridge body, etc.) to define a corresponding number of chambers.

[0106] Although the injection system shown and described herein includes a syringe with a staked needle, the needle cover operating device / retractable member described herein can be used with cartridges, autoinjectors, and injection systems with luer connectors, etc.

[0107] Various exemplary embodiments of the present invention are described herein. Reference is made to these examples in a non-restrictive sense. They are provided to illustrate the more widely applicable aspects of the present invention. Various changes may be made to the described invention and equivalents may be substituted without departing from the true spirit and scope of the present invention. In addition, many modifications may be made to adapt specific circumstances, materials, compositions of matter, methods / processes, process operations or steps to the purpose, spirit or scope of the present invention. In addition, it will be appreciated by those skilled in the art that each individual variation described and illustrated herein has discrete components and features that may be easily separated or combined from the features of any other several embodiments without departing from the scope or spirit of the present invention. All of these modifications are within the scope of the claims associated with the present disclosure.

[0108] Any of the devices described for performing the subject diagnostic or interventional procedures may be provided in a packaged combination for performing such interventions. These supply "kits" may further include instructions for use and be packaged in sterile trays or containers commonly used for this purpose.

[0109] The present invention includes methods that can be implemented using the subject device. The method can include the action of providing such suitable devices. Such provision can be performed by the end user. In other words, the "providing" action simply requires the end user to obtain, access, approach, locate, set up, activate, power on / power up, or otherwise provide the necessary devices in the subject method. The methods described herein can be performed in any order of the events described that is logically possible and in the order of the events described.

[0110] Exemplary aspects of the invention and details about material selection and manufacturing have been set forth above. As for other details of the invention, these can be understood in conjunction with the patents and publications cited above and what is generally known or understood by those skilled in the art. For example, it will be understood by those skilled in the art that, for example, if desired, one or more lubricious coatings (e.g., hydrophilic polymers, such as compositions based on polyvinyl pyrrolidone, fluoropolymers, such as tetrafluoroethylene, PTFE, ETFE, hydrophilic gels or silicones) can be used in conjunction with various parts of the device (e.g., relatively large interface surfaces of removable coupling components) to facilitate low-friction manipulation or propulsion of these objects relative to other parts of the device or nearby tissue structures. This is also true for the method-based aspects of the invention in terms of additional actions that are typically or logically employed.

[0111] In addition, although the present invention has been described with reference to several examples optionally incorporating various features, the present invention is not limited to what is described or indicated for the various variations of the present invention. Various changes may be made to the described invention, and equivalents (whether cited herein or not included for the sake of brevity) may be substituted without departing from the true spirit and scope of the present invention. In addition, where a numerical range is provided, it is understood that each intermediate value between the upper and lower limits of the range and any other stated or intermediate value within the stated range are included in the present invention.

[0112] In addition, it is contemplated that any optional features of the invention variations may be independently elaborated and claimed, or combined with any one or more features described herein. References to singular items include the possibility of multiple identical items. More specifically, as used herein and in the related claims, the singular forms "one", "an", "said" and "the" include plural objects unless otherwise specifically stated. In other words, the use of articles indicates that the items involved in "at least one" in the preceding description and claims related to the present disclosure may be referred to. It should also be noted that such claims may be written to exclude any optional elements. Therefore, this statement is intended to be used as a premise basis for the use of such exclusive terms such as "solely", "only" and the like related to the definition of claim elements or the use of "negative" type restrictions.

[0113] In the absence of such exclusive terms, the term "comprising" in the claims related to the present disclosure shall allow for the inclusion of any additional elements, regardless of whether a given number of elements are recited in such claims or the additional features may be considered to transform the nature of the elements recited in such claims. Unless otherwise specifically defined herein, all technical and scientific terms used herein are given the broadest commonly understood meaning possible while maintaining claim validity.

[0114] The scope of the present invention is not limited to the examples provided and / or the description referred to, but is limited only by the scope of the claims language associated with this disclosure.

Claims

1. A system for injection, the system for injection comprising: a syringe body having a proximal end and a distal end and defining a syringe interior; a stop member disposed inside the syringe; a plunger member coupled to the stop member and configured to be manipulated to insert the stop member distally into the interior of the syringe relative to the syringe body; A needle hub assembly coupled to the syringe body at a distal end thereof and comprising: Needle holder, and a needle coupled to the needle hub; a needle shield removably coupled to the needle hub over the needle; and A telescoping sleeve is coupled to the distal end of the syringe body and is positioned at least partially over the needle shield.

2. The system according to claim 1, wherein: The needle seat defines a circumferential groove, Wherein, the needle shield comprises an elastic material, and the elastic material is configured to interfere with a circumferential groove in the needle seat to prevent the needle shield from being separated from the needle seat.

3. The system according to claim 1, wherein: The telescoping sleeve includes a fixed member and a movable member configured to telescope relative to each other along a longitudinal axis of the telescoping sleeve.

4. The system according to claim 3, wherein: The movable member is at least partially located radially outward of the fixed component.

5. The system according to claim 3, wherein: The movable member defines an annular space, and Therein, the fixing member is at least partially arranged in the annular space.

6. The system according to claim 5, wherein: The telescopic sleeve comprises a spring arranged in the annular space radially inwardly of the fixed member, and Therein, the spring reduces the force required to remove the needle shield from the needle hub.

7. The system according to claim 6, wherein: The spring does not provide any perceptible resistance to a user administering an injection using the system.

8. The system according to claim 3, wherein: The movable member defines a plurality of inwardly extending members configured to interfere with the proximal end of the needle guard when the needle guard is coupled to the needle hub.

9. The system according to claim 8, wherein: The plurality of inwardly extending members are configured to apply a distal force from the movable member toward the proximal end of the needle guard when the needle guard is coupled to the needle hub.

10. The system according to claim 3, wherein: The fixing member defines an outwardly extending flange at a distal end thereof, wherein the movable member defines an inwardly extending flange at a proximal end thereof, and Wherein, the outwardly extending flange and the inwardly extending flange are configured to interfere with each other to limit the distal movement of the movable member relative to the fixed member.

11. The system according to claim 3, wherein: The movable member defines an inclined outer surface configured to facilitate application of a distally directed force to the movable member of the telescoping sleeve.

12. The system according to claim 3, wherein: The telescopic sleeve has a retracted configuration and an extended configuration. wherein the fixed member and the movable member substantially overlap each other when the telescoping sleeve is in the retracted configuration, and Wherein, when the telescoping sleeve is in the extended configuration, the movable member moves distally relative to the fixed member, wherein an overlap between the fixed member and the movable member is minimal.

13. The system according to claim 12, wherein: The telescopic sleeve also has a fully retracted configuration. wherein the fixing member defines a side opening, Wherein, the movable member includes a latch configured to enter the opening when the telescoping sleeve is in a fully retracted configuration, thereby preventing the movable member from moving distally relative to the fixed member.

14. The system according to claim 12, wherein: When the telescoping sleeve is in the extended configuration, the distal end of the movable member is substantially aligned with the distal tip of the needle along the longitudinal axis of the system.

15. The system of claim 12, wherein: When the telescoping sleeve is in the extended configuration, the distal end of the movable member prevents the distal tip of the needle from being visible from the proximal side of the movable member.

16. The system of claim 12, wherein: The distal end of the movable member is configured to contact the patient's skin substantially simultaneously with the distal tip of the needle during an injection using the system when the telescoping sleeve is in the extended configuration.

17. The system of claim 1, wherein: Also included is a retaining clip configured to secure the telescoping sleeve to the needle hub.

18. The system of claim 1, wherein: The movable member defines a plurality of distally extending members configured to removably retain the needle shield away from the distal end of the needle after the needle shield is removed from the needle hub.

19. The system of claim 18, wherein: Each of the plurality of distally extending members defines an inwardly extending rib configured to contact the needle shield after the needle shield is removed from the needle hub.

20. The system of claim 1, wherein: The movable member defines a substantially planar distally-facing surface.

21. The system of claim 1, further comprising a safety retraction system configured to at least partially retract the needle into the syringe body after an injection is completed using the system, such that the distal end of the needle is disposed within the needle seat or within the syringe body.

22. The system of claim 3, wherein: The movable member defines a pair of inwardly extending latches configured to interfere with the proximal end of the needle guard when the needle guard is coupled to the needle hub.

23. The system of claim 22, wherein: The pair of inwardly extending latches are configured to apply a distal force from the movable member to the proximal end of the needle shield when the needle shield is coupled to the needle hub.

24. The system of claim 22, wherein: The telescopic sleeve has a retracted configuration and an extended configuration. wherein the movable member substantially covers the fixed member when the telescoping sleeve is in the retracted configuration, and Wherein, when the telescopic sleeve is in the extended configuration, the movable member moves to the distal side relative to the fixed member.

25. The system of claim 24, wherein: The fixing member defines a pair of notches, wherein when the telescopic member is in the retracted configuration or the extended configuration, the pair of inwardly extending latch teeth are partially disposed in the pair of notches, and Wherein, the pair of inwardly extending latches are configured to interfere with corresponding proximally facing surfaces at distal ends of the pair of notches to limit distal movement of the movable member relative to the fixed member.

26. The system of claim 24, wherein: The fixed member defines a plurality of inwardly extending pads configured to contact an inner surface of the movable member to retain the telescoping member in the extended configuration.

27. The system of claim 24, wherein: The securing member defines an inwardly extending rib configured to contact the needle shield after the needle shield is removed from the needle hub.

28. The system of claim 24, wherein: The telescopic sleeve also has a fully retracted configuration. Wherein, the pair of inwardly extending latches are further configured to interfere with a proximal surface of the fixed member when the telescoping sleeve is in a fully retracted configuration, thereby preventing the movable member from moving distally relative to the fixed member.

29. The system of claim 24, wherein: When the telescoping sleeve is in the retracted configuration, the distal end of the movable member is substantially aligned with the distal tip of the needle along the longitudinal axis of the system.